Literature DB >> 7662600

Acute and subacute effects of nicorandil and isosorbide dinitrate on vessel wall properties of large arteries and hemodynamics in healthy volunteers.

M J Kool1, J J Spek, H A Struyker Boudier, A P Hoeks, R S Reneman, R H van Herwaarden, L M Van Bortel.   

Abstract

Nicorandil (N) and isosorbide dinitrate (ISDN) are vasodilator drugs used in patients with angina. In 24 healthy male volunteers (18-32 years), the acute effect of a single oral dose (20 mg) of N and ISDN on arterial diameter (D), distensibility, and compliance of the elastic common carotid artery (CCA) and the muscular femoral (FA) and brachial (BA) arteries were investigated. The effects on systolic and diastolic blood pressure (SBP, DBP), heart rate (HR), cardiac index (CI), systemic vascular resistance index (SVRI), and venous hemodynamics were also assessed. In addition, the subacute effects after 8 days of treatment with N (2 x 20 mg/day) and ISDN (3 x 20 mg/day) on these parameters were evaluated. After a 20 mg single oral dose, blood pressure decreased significantly more with ISDN (SBP: 6%; DBP: 14%) than with N (SBP: 2%; DBP: 6%), but after 8 days this decrease in blood pressure was not statistically different between ISDN and N. The diameter of CCA increased more with ISDN (11%) than N (5%) acutely as well as subacutely (ISDN: 12%; N: 9%). Heart rate increased only with ISDN (7% acutely, 3% subacutely). No differences between ISDN and nicorandil were found for acute and subacute effects on SVRI, venous hemodynamics, diameter of muscular arteries (FA, BA), and the distensibility and compliance of elastic (CCA) and muscular (FA, BA) arteries.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7662600     DOI: 10.1007/bf00878678

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  36 in total

1.  Preferential small arteriolar vasodilatation by the potassium channel opener, BRL 38227, in conscious spontaneously hypertensive rats.

Authors:  H A Struijker Boudier; M W Messing; H van Essen
Journal:  Eur J Pharmacol       Date:  1992-07-21       Impact factor: 4.432

2.  Strain gauge plethysmography in the study of circulation of the limbs.

Authors:  S Forconi; A Jageneau; M Guerrini; S Pecchi; R Cappelli
Journal:  Angiology       Date:  1979-07       Impact factor: 3.619

3.  The diameter of the intact carotid artery in man and its change with pulse pressure.

Authors:  J O Arndt; J Klauske; F Mersch
Journal:  Pflugers Arch Gesamte Physiol Menschen Tiere       Date:  1968

4.  Evaluation of reproducibility of a vessel wall movement detector system for assessment of large artery properties.

Authors:  M J Kool; T van Merode; R S Reneman; A P Hoeks; H A Struyker Boudier; L M Van Bortel
Journal:  Cardiovasc Res       Date:  1994-05       Impact factor: 10.787

5.  Peripheral large arteries and the response to antihypertensive treatment.

Authors:  M E Safar; J A Bouthier; J A Levenson; A C Simon
Journal:  Hypertension       Date:  1983 Sep-Oct       Impact factor: 10.190

Review 6.  Hypertension and the arterial system: clinical and therapeutic aspects.

Authors:  M E Safar; B I Levy; S Laurent; G M London
Journal:  J Hypertens Suppl       Date:  1990-12

7.  Isosorbide dinitrate. Effect on the vasodilator response to nitroglycerin.

Authors:  R Zelis; D T Mason
Journal:  JAMA       Date:  1975-10-13       Impact factor: 56.272

8.  Isosorbide dinitrate: relationship between pharmacokinetics and brachial artery hemodynamics in essential hypertension.

Authors:  A M Frydman; M E Safar; A C Simon; J A Levenson; J Gaillot; E Roland
Journal:  Angiology       Date:  1986-08       Impact factor: 3.619

9.  Different susceptibility to the development of nitroglycerin tolerance in the arterial and venous circulation in humans. Effects of N-acetylcysteine administration.

Authors:  S Ghio; S de Servi; R Perotti; E Eleuteri; C Montemartini; G Specchia
Journal:  Circulation       Date:  1992-09       Impact factor: 29.690

Review 10.  Nicorandil as a hybrid between nitrates and potassium channel activators.

Authors:  N Taira
Journal:  Am J Cardiol       Date:  1989-06-20       Impact factor: 2.778

View more
  6 in total

Review 1.  Pharmacological modulation of arterial stiffness.

Authors:  Pierre Boutouyrie; Patrick Lacolley; Marie Briet; Véronique Regnault; Alice Stanton; Stéphane Laurent; Azra Mahmud
Journal:  Drugs       Date:  2011-09-10       Impact factor: 9.546

Review 2.  Nicorandil and Long-acting Nitrates: Vasodilator Therapies for the Management of Chronic Stable Angina Pectoris.

Authors:  Jason M Tarkin; Juan Carlos Kaski
Journal:  Eur Cardiol       Date:  2018-08

3.  [Nicorandil: acute hemodynamic effects of 2 different oral doses of a potassium channel opener in patients with coronary heart disease].

Authors:  C Bickel; H J Rupprecht; A Tyrtania; J Rörig; J Meyer
Journal:  Med Klin (Munich)       Date:  1999-02-15

Review 4.  The Role of Nicorandil in the Management of Chronic Coronary Syndromes in the Gulf Region.

Authors:  Kevin Cheng; Khaldoon Alhumood; Fayez El Shaer; Ranil De Silva
Journal:  Adv Ther       Date:  2020-12-22       Impact factor: 3.845

5.  Prognostic Impact of Chronic Vasodilator Therapy in Patients With Vasospastic Angina.

Authors:  Yongwhan Lim; Min Chul Kim; Youngkeun Ahn; Kyung Hoon Cho; Doo Sun Sim; Young Joon Hong; Ju Han Kim; Myung Ho Jeong; Sang Hong Baek; Sung-Ho Her; Kwan Yong Lee; Seung Hwan Han; Seung-Woon Rha; Dong-Ju Choi; Hyeon-Cheol Gwon; Hyuck Moon Kwon; Tae-Hyun Yang; Keun-Ho Park; Sang-Ho Jo
Journal:  J Am Heart Assoc       Date:  2022-03-29       Impact factor: 5.501

Review 6.  Vasodilator Therapy: Nitrates and Nicorandil.

Authors:  Jason M Tarkin; Juan Carlos Kaski
Journal:  Cardiovasc Drugs Ther       Date:  2016-08       Impact factor: 3.727

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.